Nuclear Factor κB-COX2 Pathway Activation in Non-myelinating Schwann Cells Is Necessary for the Maintenance of Neuropathic Pain

Overview

Journal Front Cell Neurosci

Specialty Cell Biology

Date 2022 Jan 31

PMID 35095422

Authors

Alison Xiaoqiao Xie

Sarah Taves

Ken McCarthy

Affiliations

Soon will be listed here.

Abstract

Chronic neuropathic pain leads to long-term changes in the sensitivity of both peripheral and central nociceptive neurons. Glial fibrillary acidic protein (GFAP)-positive glial cells are closely associated with the nociceptive neurons including astrocytes in the central nervous system (CNS), satellite glial cells (SGCs) in the sensory ganglia, and non-myelinating Schwann cells (NMSCs) in the peripheral nerves. Central and peripheral GFAP-positive cells are involved in the maintenance of chronic pain through a host of inflammatory cytokines, many of which are under control of the transcription factor nuclear factor κB (NFκB) and the enzyme cyclooxygenase 2 (COX2). To test the hypothesis that inhibiting GFAP-positive glial signaling alleviates chronic pain, we used (1) a conditional knockout (cKO) mouse expressing Cre recombinase under the hGFAP promoter and a floxed COX2 gene to inactivate the COX2 gene specifically in GFAP-positive cells; and (2) a tet-Off tetracycline transactivator system to suppress NFκB activation in GFAP-positive cells. We found that neuropathic pain behavior following spared nerve injury (SNI) significantly decreased in COX2 cKO mice as well as in mice with decreased glial NFκB signaling. Additionally, experiments were performed to determine whether central or peripheral glial NFκB signaling contributes to the maintenance of chronic pain behavior following nerve injury. Oxytetracycline (Oxy), a blood-brain barrier impermeable analog of doxycycline was employed to restrict transgene expression to CNS glia only, leaving peripheral glial signaling intact. Signaling inactivation in central GFAP-positive glia alone failed to exhibit the same analgesic effects as previously observed in animals with both central and peripheral glial signaling inhibition. These data suggest that the NFκB-COX2 signaling pathway in NMSCs is necessary for the maintenance of neuropathic pain .

Citing Articles

Accumulation of advanced oxidative protein products exacerbate satellite glial cells activation and neuropathic pain.

Tu C, Wang S, Dai M, Lai S, Huang Z, Yu Y Mol Med. 2025; 31(1):25.

PMID: 39865234 PMC: 11765935. DOI: 10.1186/s10020-025-01076-x.

Multilevel analysis of the central-peripheral-target organ pathway: contributing to recovery after peripheral nerve injury.

Song X, Li R, Chu X, Li Q, Li R, Li Q Neural Regen Res. 2024; 20(10):2807-2822.

PMID: 39435615 PMC: 11826472. DOI: 10.4103/NRR.NRR-D-24-00641.

Naturally Inspired Molecules for Neuropathic Pain Inhibition-Effect of Mirogabalin and Cebranopadol on Mechanical and Thermal Nociceptive Threshold in Mice.

Salat K, Zareba P, Awtoniuk M, Salat R Molecules. 2023; 28(23).

PMID: 38067591 PMC: 10708129. DOI: 10.3390/molecules28237862.

Modelling skeletal pain harnessing tissue engineering.

Iafrate L, Benedetti M, Donsante S, Rosa A, Corsi A, Oreffo R In Vitro Model. 2022; 1(4-5):289-307.

PMID: 36567849 PMC: 9766883. DOI: 10.1007/s44164-022-00028-7.

References

Campana W . Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav Immun. 2007; 21(5):522-7. PMC: 2219463. DOI: 10.1016/j.bbi.2006.12.008. View

Huber M, Denk A, Peter R, Weber L, Kraut N, Wirth T . The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice. J Biol Chem. 2001; 277(2):1268-75. DOI: 10.1074/jbc.M109358200. View

Shields S, Eckert 3rd W, Basbaum A . Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis. J Pain. 2003; 4(8):465-70. DOI: 10.1067/s1526-5900(03)00781-8. View

Zhuang Z, Wen Y, Zhang D, Borsello T, Bonny C, Strichartz G . A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci. 2006; 26(13):3551-60. PMC: 6673862. DOI: 10.1523/JNEUROSCI.5290-05.2006. View

ONeill L, Kaltschmidt C . NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997; 20(6):252-8. DOI: 10.1016/s0166-2236(96)01035-1. View

Meller S, Dykstra C, Grzybycki D, Murphy S, Gebhart G . The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology. 1994; 33(11):1471-8. DOI: 10.1016/0028-3908(94)90051-5. View

Chaplan S, Bach F, Pogrel J, Chung J, Yaksh T . Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994; 53(1):55-63. DOI: 10.1016/0165-0270(94)90144-9. View

Barza M, Brown R, Shanks C, Gamble C, WEINSTEIN L . Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother. 1975; 8(6):713-20. PMC: 429453. DOI: 10.1128/AAC.8.6.713. View

Wewetzer K, Grothe C, Christ B, Seilheimer B . Identification and characterization of differentiation-dependent Schwann cell surface antigens by novel monoclonal antibodies: introduction of a marker common to the non-myelin-forming phenotype. Glia. 1997; 19(3):213-26. DOI: 10.1002/(sici)1098-1136(199703)19:3<213::aid-glia4>3.0.co;2-#. View

10.

Milligan E, Watkins L . Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2008; 10(1):23-36. PMC: 2752436. DOI: 10.1038/nrn2533. View

11.

Syriatowicz J, Hu D, Walker J, Tracey D . Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience. 1999; 94(2):587-94. DOI: 10.1016/s0306-4522(99)00365-6. View

12.

Meunier A, Latremoliere A, Dominguez E, Mauborgne A, Philippe S, Hamon M . Lentiviral-mediated Targeted NF-κB Blockade in Dorsal Spinal Cord Glia Attenuates Sciatic Nerve Injury-induced Neuropathic Pain in the Rat. Mol Ther. 2017; 15(4):687-697. DOI: 10.1038/sj.mt.6300107. View

13.

Takeda K, Sawamura S, Tamai H, Sekiyama H, Hanaoka K . Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation. Anesthesiology. 2005; 103(4):837-44. DOI: 10.1097/00000542-200510000-00023. View

14.

Fu E, Zhang Y, Sagen J, Candiotti K, Morton P, Liebl D . Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain. 2010; 148(3):509-518. PMC: 2853034. DOI: 10.1016/j.pain.2010.01.001. View

15.

Myers R, Heckman H, Rodriguez M . Reduced hyperalgesia in nerve-injured WLD mice: relationship to nerve fiber phagocytosis, axonal degeneration, and regeneration in normal mice. Exp Neurol. 1996; 141(1):94-101. DOI: 10.1006/exnr.1996.0142. View

16.

Herrmann O, Baumann B, De Lorenzi R, Muhammad S, Zhang W, Kleesiek J . IKK mediates ischemia-induced neuronal death. Nat Med. 2005; 11(12):1322-9. DOI: 10.1038/nm1323. View

17.

Romero-Sandoval E, Horvath R, DeLeo J . Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs. 2008; 9(7):726-34. PMC: 2696046. View

18.

Adcock I, Newton R, Barnes P . NF-kappa B involvement in IL-1 beta-induction of GM-CSF and COX-2: inhibition by glucocorticoids does not require I-kappa B. Biochem Soc Trans. 1997; 25(2):154S. DOI: 10.1042/bst025154s. View

19.

Broom D, Samad T, Kohno T, Tegeder I, Geisslinger G, Woolf C . Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience. 2004; 124(4):891-900. DOI: 10.1016/j.neuroscience.2004.01.003. View

20.

Milligan E, Twining C, Chacur M, Biedenkapp J, OConnor K, Poole S . Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci. 2003; 23(3):1026-40. PMC: 6741915. View